These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


68 related items for PubMed ID: 6286927

  • 1. Solubilization and characterization of active opiate binding sites from mammalian brain.
    Howells RD, Gioannini TL, Hiller JM, Simon EJ.
    J Pharmacol Exp Ther; 1982 Sep; 222(3):629-34. PubMed ID: 6286927
    [Abstract] [Full Text] [Related]

  • 2. Solubilization in good yield of active opiate binding sites from mammalian brain.
    Gioannini TL, Howells RD, Hiller JM, Simon EJ.
    Life Sci; 1982 Sep; 31(12-13):1315-8. PubMed ID: 6292621
    [Abstract] [Full Text] [Related]

  • 3. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T, Zukin RS.
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [Abstract] [Full Text] [Related]

  • 4. Characterization of solubilized serotonin (S2) receptors in rat brain.
    Ilien B, Gorissen H, Laduron PM.
    Mol Pharmacol; 1982 Sep; 22(2):243-9. PubMed ID: 7144728
    [Abstract] [Full Text] [Related]

  • 5. Characterization and partial purification of solubilized active opiate receptors from toad brain.
    Ruegg UT, Cuenod S, Hiller JM, Gioannini T, Howells RD, Simon EJ.
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4635-8. PubMed ID: 6270689
    [Abstract] [Full Text] [Related]

  • 6. Solubilization and purification of opioid receptor molecules of rat brain.
    Jin YC, Ye CY, Li Y, Suo CL, Li LY, Liu MQ, Jin XM, Mao ZM.
    Proc Chin Acad Med Sci Peking Union Med Coll; 1989 Jul; 4(1):1-7. PubMed ID: 2540493
    [Abstract] [Full Text] [Related]

  • 7. Solubilization and characterization of [3H] 5HT high affinity binding sites (5HT1 and 5HT3).
    Rousselle JC, Gillet G, Fillion G.
    J Pharmacol; 1985 Jul; 16(4):421-38. PubMed ID: 4094438
    [Abstract] [Full Text] [Related]

  • 8. Solubilization in high yield of opioid receptors retaining high-affinity delta, mu and kappa binding sites.
    Demoliou-Mason CD, Barnard EA.
    FEBS Lett; 1984 May 21; 170(2):378-82. PubMed ID: 6144572
    [Abstract] [Full Text] [Related]

  • 9. Solubilization of an active opiate receptor from Bufo marinus.
    Rüegg UT, Hiller JM, Simon EJ.
    Eur J Pharmacol; 1980 Jun 27; 64(4):367-8. PubMed ID: 6248353
    [No Abstract] [Full Text] [Related]

  • 10. Opiate binding sites in the retina: properties and distribution.
    Howells RD, Groth J, Hiller JM, Simon EJ.
    J Pharmacol Exp Ther; 1980 Oct 27; 215(1):60-4. PubMed ID: 6256520
    [Abstract] [Full Text] [Related]

  • 11. Effect of digitonin on the binding of opiate agonists and antagonists to membrane-bound and soluble opioid binding sites.
    Itzhak Y, Hiller JM, Gioannini TL, Simon EJ.
    Brain Res; 1984 Jan 23; 291(2):309-15. PubMed ID: 6320961
    [Abstract] [Full Text] [Related]

  • 12. Lectin binding of solubilized opiate receptors: evidence for their glycoprotein nature.
    Gioannini T, Foucaud B, Hiller JM, Hatten ME, Simon EJ.
    Biochem Biophys Res Commun; 1982 Apr 14; 105(3):1128-34. PubMed ID: 6284164
    [No Abstract] [Full Text] [Related]

  • 13. Solubilization of kainic acid binding sites from rat brain.
    Hampson DR, Huie D, Wenthold RJ.
    J Neurochem; 1987 Oct 14; 49(4):1209-15. PubMed ID: 3040908
    [Abstract] [Full Text] [Related]

  • 14. Affinity chromatography of solubilized opioid binding sites using CH-Sepharose modified with a new naltrexone derivative.
    Gioannini TL, Howard A, Hiller JM, Simon EJ.
    Biochem Biophys Res Commun; 1984 Mar 15; 119(2):624-9. PubMed ID: 6324770
    [Abstract] [Full Text] [Related]

  • 15. [Solubilization and purification of opioid receptor molecules of rat brain].
    Jin YC.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Apr 15; 11(2):79-86. PubMed ID: 2550157
    [Abstract] [Full Text] [Related]

  • 16. [Opiate receptor(s) of the frog brain: soluble-phase separation of the macromolecular complexes of an agonist and an antagonist].
    Puget A, Meunier JC.
    C R Seances Acad Sci III; 1983 Apr 15; 296(10):475-8. PubMed ID: 6307492
    [Abstract] [Full Text] [Related]

  • 17. Solubilization and characterization of a guanine nucleotide-sensitive form of the calcitonin gene-related peptide receptor.
    Chatterjee TK, Moy JA, Cai JJ, Lee HC, Fisher RA.
    Mol Pharmacol; 1993 Feb 15; 43(2):167-75. PubMed ID: 8381507
    [Abstract] [Full Text] [Related]

  • 18. Selective solubilization of physalaemin-type substance P binding sites from rat brain membranes by glycodeoxycholate and NaCl.
    Maruyama M.
    Brain Res; 1986 Apr 02; 370(1):186-90. PubMed ID: 3011190
    [Abstract] [Full Text] [Related]

  • 19. Further studies on the role of phospholipids in determining the characteristics of mitochondrial binding sites for type I hexokinase.
    Hutny J, Wilson JE.
    Acta Biochim Pol; 2000 Apr 02; 47(4):1045-60. PubMed ID: 11996095
    [Abstract] [Full Text] [Related]

  • 20. Determination of the sizes of the opioid receptors in their membrane environment by radiation inactivation.
    Tao PL, Chang LR, Lee HK, Loh HH.
    Proc Natl Sci Counc Repub China B; 1986 Jul 02; 10(3):184-90. PubMed ID: 3022321
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.